MONDAY, June 1, 2020 (HealthDay News) -- Tauvid (flortaucipir F18), a radioactive diagnostic agent, was approved to image tau pathology in patients with cognitive impairment being evaluated for Alzheimer disease, the U.S. Food and Drug Administration ...
from Google Alert - health https://ift.tt/2XSd0Mc
via IFTTT
0 comments:
Post a Comment